At the time of writing, Unity Biotechnology Inc [UBX] stock is trading at $0.81, up 16.00%. An important factor to consider is whether the stock is rising or falling in short-term value. The UBX shares have gain 13.27% over the last week, with a monthly amount drifted -11.39%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Unity Biotechnology Inc [NASDAQ: UBX] stock has seen the most recent analyst activity on May 27, 2025, when H.C. Wainwright downgraded its rating to a Neutral but kept the price target unchanged to $2 for it. Previously, Mizuho downgraded its rating to Neutral on May 16, 2025, and dropped its price target to $1. On August 22, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $8 on the stock. Wedbush upgraded its rating to a Outperform and increased its price target to $4 on November 16, 2023. ROTH Capital upgraded its rating to a Buy. Mizuho upgraded its rating to Buy for this stock on November 10, 2021, and upped its price target to $7. In a note dated June 28, 2021, Citigroup upgraded an Buy rating on this stock but restated the target price of $6.
For the past year, the stock price of Unity Biotechnology Inc fluctuated between $0.66 and $3.10. Currently, Wall Street analysts expect the stock to reach $2.5 within the next 12 months. Unity Biotechnology Inc [NASDAQ: UBX] shares were valued at $0.81 at the most recent close of the market. An investor can expect a potential return of 208.64% based on the average UBX price forecast.
Analyzing the UBX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.91, Equity is -2.74 and Total Capital is -1.41. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-91.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Unity Biotechnology Inc [NASDAQ:UBX] has a current ratio of 1.95. On the other hand, the Quick Ratio is 1.95, and the Cash Ratio is 0.88.
Transactions by insiders
Recent insider trading involved Nguyen Alexander Hieu, CLO and Head of Ops, that happened on Apr 02 ’25 when 17852.0 shares were sold. Officer, Nguyen Alexander Hieu completed a deal on Apr 02 ’25 to buy 17852.0 shares. Meanwhile, CFO & Head of Corp. Dev. Sullivan Lynne Marie sold 21867.0 shares on Apr 02 ’25.
